Chapter 18
Dopaminergic strategies, enzyme inhibitors, amantadine, anticholinergic agents, and pharmacological management of the non-motor features of Parkinson's disease.
Modules & Question Sets
Module 1
Pathophysiology and Drug Strategy Overview
Module 2
Levodopa and Carbidopa
Module 3
Motor Complications of Levodopa Therapy
Module 4
Dopamine Agonists
Module 5
Enzyme Inhibitors: Monoamine Oxidase B Inhibitors and Catechol-O-Methyltransferase Inhibitors
Module 6
Amantadine and Anticholinergic Agents
Module 7
Non-Motor Symptoms and Their Pharmacological Management